Predicting the no-reflow phenomenon in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a systematic review of clinical prediction models
Background: The no-reflow (NRF) phenomenon is the “Achilles heel” of interventionists after performing percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI). No definitive treatment has been proposed for NRF, and preventive strategies are centra...
Saved in:
Published in | Therapeutic advances in cardiovascular disease Vol. 18; p. 17539447241290438 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
London, England
SAGE Publications
01.01.2024
SAGE PUBLICATIONS, INC SAGE Publishing |
Subjects | |
Online Access | Get full text |
ISSN | 1753-9447 1753-9455 1753-9455 |
DOI | 10.1177/17539447241290438 |
Cover
Abstract | Background:
The no-reflow (NRF) phenomenon is the “Achilles heel” of interventionists after performing percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI). No definitive treatment has been proposed for NRF, and preventive strategies are central to improving care for patients who develop NRF.
Objectives:
In this study, we aim to investigate the clinical prediction models developed to predict NRF in STEMI patients undergoing primary PCI.
Design:
Systematic review.
Data sources and methods:
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were observed. Studies that developed clinical prediction modeling for NRF after primary PCI in STEMI patients were included. Data extraction was performed using the Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS) checklist. The Prediction Model Risk of Bias Assessment Tool (PROBAST) tool was used for critical appraisal of the included studies.
Results:
The three most common predictors were age, total ischemic time, and preoperative thrombolysis in myocardial infarction flow grade. Most of the included studies internally validated their developed model via various methods: random split, bootstrapping, and cross-validation. Only three studies (18%) externally validated their model. Six studies (37%) reported a calibration plot with or without the Hosmer–Lemeshow test. The reported area under the curve ranged from 0.648 to 0.925. The most common biases were in the statistical domain.
Conclusion:
Clinical prediction models aid in individualizing care for STEMI patients with NRF after primary PCI. Of the 16 included studies, we report four to have a low risk of bias and low concern with regard to our research question, which should undergo external validation with or without updating in future studies.
Jargon summary
Introduction: Heart attacks, or acute myocardial infarctions (MI), are severe consequences of coronary artery disease. One type, ST-segment elevation myocardial infarction (STEMI), requires prompt treatment to restore blood flow and prevent severe complications. The preferred treatment is primary percutaneous coronary intervention (PCI). However, sometimes blood flow remains poor despite successful PCI, a condition known as the no-reflow (NRF) phenomenon, which can lead to worse outcomes.
Study Goal: This study reviews and evaluates existing models that predict NRF in STEMI patients undergoing PCI to help doctors identify and prevent this complication.
Methods: We systematically searched databases for studies on NRF prediction models in STEMI patients. We included studies that developed these models and evaluated their risk of bias and applicability.
Key Findings:
- Search Results: Out of 7,095 citations, 16 studies were reviewed.
- Study Locations: Studies were mainly conducted in China, Turkey, and a few other countries.
- Predictors: Common predictors of NRF included age, total ischemic time, and preoperative blood flow. The models used various data like patient demographics, lab results, and clinical observations.
- Model Performance: Models showed varying levels of accuracy in predicting NRF. Most models used logistic regression for development. Internal validation was done in several studies, but external validation was limited.
Implications:
- Clinical Use: Predictive models can help in timely decision-making during PCI. However, current models need more validation and improvement in their design to be widely accepted in clinical practice.
- Future Research: More robust, prospective studies are needed, especially in diverse populations, to develop and validate better prediction models.
Conclusion: This review highlights the need for better predictive models for NRF in STEMI patients. Existing models show promise but require further refinement and validation to improve their clinical utility. |
---|---|
AbstractList | The no-reflow (NRF) phenomenon is the "Achilles heel" of interventionists after performing percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI). No definitive treatment has been proposed for NRF, and preventive strategies are central to improving care for patients who develop NRF.
In this study, we aim to investigate the clinical prediction models developed to predict NRF in STEMI patients undergoing primary PCI.
Systematic review.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were observed. Studies that developed clinical prediction modeling for NRF after primary PCI in STEMI patients were included. Data extraction was performed using the Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS) checklist. The Prediction Model Risk of Bias Assessment Tool (PROBAST) tool was used for critical appraisal of the included studies.
The three most common predictors were age, total ischemic time, and preoperative thrombolysis in myocardial infarction flow grade. Most of the included studies internally validated their developed model via various methods: random split, bootstrapping, and cross-validation. Only three studies (18%) externally validated their model. Six studies (37%) reported a calibration plot with or without the Hosmer-Lemeshow test. The reported area under the curve ranged from 0.648 to 0.925. The most common biases were in the statistical domain.
Clinical prediction models aid in individualizing care for STEMI patients with NRF after primary PCI. Of the 16 included studies, we report four to have a low risk of bias and low concern with regard to our research question, which should undergo external validation with or without updating in future studies. The no-reflow (NRF) phenomenon is the "Achilles heel" of interventionists after performing percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI). No definitive treatment has been proposed for NRF, and preventive strategies are central to improving care for patients who develop NRF.BACKGROUNDThe no-reflow (NRF) phenomenon is the "Achilles heel" of interventionists after performing percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI). No definitive treatment has been proposed for NRF, and preventive strategies are central to improving care for patients who develop NRF.In this study, we aim to investigate the clinical prediction models developed to predict NRF in STEMI patients undergoing primary PCI.OBJECTIVESIn this study, we aim to investigate the clinical prediction models developed to predict NRF in STEMI patients undergoing primary PCI.Systematic review.DESIGNSystematic review.Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were observed. Studies that developed clinical prediction modeling for NRF after primary PCI in STEMI patients were included. Data extraction was performed using the Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS) checklist. The Prediction Model Risk of Bias Assessment Tool (PROBAST) tool was used for critical appraisal of the included studies.DATA SOURCES AND METHODSPreferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were observed. Studies that developed clinical prediction modeling for NRF after primary PCI in STEMI patients were included. Data extraction was performed using the Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS) checklist. The Prediction Model Risk of Bias Assessment Tool (PROBAST) tool was used for critical appraisal of the included studies.The three most common predictors were age, total ischemic time, and preoperative thrombolysis in myocardial infarction flow grade. Most of the included studies internally validated their developed model via various methods: random split, bootstrapping, and cross-validation. Only three studies (18%) externally validated their model. Six studies (37%) reported a calibration plot with or without the Hosmer-Lemeshow test. The reported area under the curve ranged from 0.648 to 0.925. The most common biases were in the statistical domain.RESULTSThe three most common predictors were age, total ischemic time, and preoperative thrombolysis in myocardial infarction flow grade. Most of the included studies internally validated their developed model via various methods: random split, bootstrapping, and cross-validation. Only three studies (18%) externally validated their model. Six studies (37%) reported a calibration plot with or without the Hosmer-Lemeshow test. The reported area under the curve ranged from 0.648 to 0.925. The most common biases were in the statistical domain.Clinical prediction models aid in individualizing care for STEMI patients with NRF after primary PCI. Of the 16 included studies, we report four to have a low risk of bias and low concern with regard to our research question, which should undergo external validation with or without updating in future studies.CONCLUSIONClinical prediction models aid in individualizing care for STEMI patients with NRF after primary PCI. Of the 16 included studies, we report four to have a low risk of bias and low concern with regard to our research question, which should undergo external validation with or without updating in future studies. Background: The no-reflow (NRF) phenomenon is the “Achilles heel” of interventionists after performing percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI). No definitive treatment has been proposed for NRF, and preventive strategies are central to improving care for patients who develop NRF. Objectives: In this study, we aim to investigate the clinical prediction models developed to predict NRF in STEMI patients undergoing primary PCI. Design: Systematic review. Data sources and methods: Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were observed. Studies that developed clinical prediction modeling for NRF after primary PCI in STEMI patients were included. Data extraction was performed using the Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS) checklist. The Prediction Model Risk of Bias Assessment Tool (PROBAST) tool was used for critical appraisal of the included studies. Results: The three most common predictors were age, total ischemic time, and preoperative thrombolysis in myocardial infarction flow grade. Most of the included studies internally validated their developed model via various methods: random split, bootstrapping, and cross-validation. Only three studies (18%) externally validated their model. Six studies (37%) reported a calibration plot with or without the Hosmer–Lemeshow test. The reported area under the curve ranged from 0.648 to 0.925. The most common biases were in the statistical domain. Conclusion: Clinical prediction models aid in individualizing care for STEMI patients with NRF after primary PCI. Of the 16 included studies, we report four to have a low risk of bias and low concern with regard to our research question, which should undergo external validation with or without updating in future studies. Jargon summary Introduction: Heart attacks, or acute myocardial infarctions (MI), are severe consequences of coronary artery disease. One type, ST-segment elevation myocardial infarction (STEMI), requires prompt treatment to restore blood flow and prevent severe complications. The preferred treatment is primary percutaneous coronary intervention (PCI). However, sometimes blood flow remains poor despite successful PCI, a condition known as the no-reflow (NRF) phenomenon, which can lead to worse outcomes. Study Goal: This study reviews and evaluates existing models that predict NRF in STEMI patients undergoing PCI to help doctors identify and prevent this complication. Methods: We systematically searched databases for studies on NRF prediction models in STEMI patients. We included studies that developed these models and evaluated their risk of bias and applicability. Key Findings: - Search Results: Out of 7,095 citations, 16 studies were reviewed. - Study Locations: Studies were mainly conducted in China, Turkey, and a few other countries. - Predictors: Common predictors of NRF included age, total ischemic time, and preoperative blood flow. The models used various data like patient demographics, lab results, and clinical observations. - Model Performance: Models showed varying levels of accuracy in predicting NRF. Most models used logistic regression for development. Internal validation was done in several studies, but external validation was limited. Implications: - Clinical Use: Predictive models can help in timely decision-making during PCI. However, current models need more validation and improvement in their design to be widely accepted in clinical practice. - Future Research: More robust, prospective studies are needed, especially in diverse populations, to develop and validate better prediction models. Conclusion: This review highlights the need for better predictive models for NRF in STEMI patients. Existing models show promise but require further refinement and validation to improve their clinical utility. Background: The no-reflow (NRF) phenomenon is the “Achilles heel” of interventionists after performing percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI). No definitive treatment has been proposed for NRF, and preventive strategies are central to improving care for patients who develop NRF. Objectives: In this study, we aim to investigate the clinical prediction models developed to predict NRF in STEMI patients undergoing primary PCI. Design: Systematic review. Data sources and methods: Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were observed. Studies that developed clinical prediction modeling for NRF after primary PCI in STEMI patients were included. Data extraction was performed using the Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies (CHARMS) checklist. The Prediction Model Risk of Bias Assessment Tool (PROBAST) tool was used for critical appraisal of the included studies. Results: The three most common predictors were age, total ischemic time, and preoperative thrombolysis in myocardial infarction flow grade. Most of the included studies internally validated their developed model via various methods: random split, bootstrapping, and cross-validation. Only three studies (18%) externally validated their model. Six studies (37%) reported a calibration plot with or without the Hosmer–Lemeshow test. The reported area under the curve ranged from 0.648 to 0.925. The most common biases were in the statistical domain. Conclusion: Clinical prediction models aid in individualizing care for STEMI patients with NRF after primary PCI. Of the 16 included studies, we report four to have a low risk of bias and low concern with regard to our research question, which should undergo external validation with or without updating in future studies. Jargon summary Introduction: Heart attacks, or acute myocardial infarctions (MI), are severe consequences of coronary artery disease. One type, ST-segment elevation myocardial infarction (STEMI), requires prompt treatment to restore blood flow and prevent severe complications. The preferred treatment is primary percutaneous coronary intervention (PCI). However, sometimes blood flow remains poor despite successful PCI, a condition known as the no-reflow (NRF) phenomenon, which can lead to worse outcomes. Study Goal: This study reviews and evaluates existing models that predict NRF in STEMI patients undergoing PCI to help doctors identify and prevent this complication. Methods: We systematically searched databases for studies on NRF prediction models in STEMI patients. We included studies that developed these models and evaluated their risk of bias and applicability. Key Findings: - Search Results: Out of 7,095 citations, 16 studies were reviewed. - Study Locations: Studies were mainly conducted in China, Turkey, and a few other countries. - Predictors: Common predictors of NRF included age, total ischemic time, and preoperative blood flow. The models used various data like patient demographics, lab results, and clinical observations. - Model Performance: Models showed varying levels of accuracy in predicting NRF. Most models used logistic regression for development. Internal validation was done in several studies, but external validation was limited. Implications: - Clinical Use: Predictive models can help in timely decision-making during PCI. However, current models need more validation and improvement in their design to be widely accepted in clinical practice. - Future Research: More robust, prospective studies are needed, especially in diverse populations, to develop and validate better prediction models. Conclusion: This review highlights the need for better predictive models for NRF in STEMI patients. Existing models show promise but require further refinement and validation to improve their clinical utility. |
Author | Rahmani, Mahdi Jalali, Arash Ghaseminejad-Raeini, Amirhossein Fallahtafti, Parisa Azarboo, Alireza Mehrani, Mehdi Ebrahimi, Reza |
Author_xml | – sequence: 1 givenname: Reza orcidid: 0009-0006-2660-6176 surname: Ebrahimi fullname: Ebrahimi, Reza organization: School of Medicine, Tehran University of Medical Sciences, Tehran, Iran – sequence: 2 givenname: Mahdi surname: Rahmani fullname: Rahmani, Mahdi organization: School of Medicine, Tehran University of Medical Sciences, Tehran, Iran – sequence: 3 givenname: Parisa surname: Fallahtafti fullname: Fallahtafti, Parisa organization: Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran – sequence: 4 givenname: Amirhossein surname: Ghaseminejad-Raeini fullname: Ghaseminejad-Raeini, Amirhossein organization: School of Medicine, Tehran University of Medical Sciences, Tehran, Iran – sequence: 5 givenname: Alireza surname: Azarboo fullname: Azarboo, Alireza organization: School of Medicine, Tehran University of Medical Sciences, Tehran, Iran – sequence: 6 givenname: Arash surname: Jalali fullname: Jalali, Arash organization: Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran – sequence: 7 givenname: Mehdi surname: Mehrani fullname: Mehrani, Mehdi email: mehdi.mehrani78@gmail.com organization: Tehran Heart Center, Cardiovascular Disease Research Institute, Tehran University of Medical Sciences, Tehran 1419733141, Iran |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39470690$$D View this record in MEDLINE/PubMed |
BookMark | eNp1Uk2P0zAQjdAi9gN-ABdkiQuXLHZq1zEXhFZ8rLQSSCznaGqPW1eJHeykq_42_hzOphQWxMEae-a95-fxnBcnPngsiueMXjIm5WsmxUJxLivOKkX5on5UnE25UnEhTo57Lk-L85S2lApFpXxSnGaWpEtFz4ofXyIapwfn12TYIPGhjGjbcEf6DfrQ5eWJ8-TrbYkt7mBw-dztg4ZoHLS5ZCHq-2yfi-iHREZvMK7DJNlH10Hckx6jHgfwGMZEdIjBT1nnB4y7zMn0NwRI2qcBuyyjScSdwzsSLNGt807nq_qD08lAMNimp8VjC23CZ4d4UXz78P726lN58_nj9dW7m1LzWgylRlBiZWxN1UrYWivJDQOrAaipDK25BmqrSjMLAqRCwSpBc4AMqw3HxUVxPeuaANvm8KQmgGvuEyGuG4jZdIuNolasgNe1WeYWo1ForaCGUaBcMlllrbezVj-uOjQ6Pz5C-0D0YcW7TbMOu4axJavVcpkVXh0UYvg-YhqaziWNbTt3t1mwiuV_FoJn6Mu_oNswRp97lVGCikoxNll68aelo5dfQ5IBbAboGFLK43GEMNpMg9j8M4iZczlzEqzx97X_J_wEJN_juQ |
Cites_doi | 10.7326/M14-0698 10.1016/S0140-6736(16)30677-8 10.1016/j.jcin.2016.11.059 10.1177/0962280218784726 10.1371/journal.pmed.1001744 10.1148/radiol.2017171920 10.1016/j.cpcardiol.2020.100676 10.1136/openhrt-2019-001215 10.1016/j.jcmg.2014.06.012 10.1093/cvr/cvz301 10.1080/14779072.2019.1653187 10.1186/s12959-023-00519-x 10.1093/eurheartj/ehq299 10.1016/j.jclinepi.2015.04.005 10.1016/j.jacc.2009.12.054 10.1111/joic.12463 10.1016/j.ihj.2018.01.032 10.1097/EDE.0b013e3181c30fb2 10.1016/j.acvd.2010.09.005 10.1016/j.jacc.2007.04.084 10.1016/j.amjms.2023.06.011 10.1016/j.jacc.2009.03.054 10.1016/j.acvd.2015.09.006 10.3389/fcvm.2022.966299 10.12659/MSM.915960 10.1007/s12265-020-10020-9 10.1007/s10554-012-0021-9 10.1016/j.jacc.2008.04.006 10.1093/eurheartj/ehp122 10.2174/1381612824666180702112536 10.1002/clc.22376 10.1093/ehjacc/zuaa004 10.1016/j.amjcard.2022.01.044 10.36468/pharmaceutical-sciences.spl.353 10.1111/eci.13686 10.1093/eurheartj/ehx393 10.1002/sim.6080 10.1186/s12916-019-1466-7 10.1016/j.atherosclerosis.2014.03.005 10.1093/ehjci/jev341 10.1007/978-0-387-77244-8 10.1177/00033197211045021 10.2147/TCRM.S353199 10.7326/M18-1377 10.1016/j.ihj.2016.04.006 10.1016/j.jclinepi.2010.11.012 10.7326/M18-1376 10.1097/MCA.0b013e32834f1b8a 10.21037/atm-20-8003 10.1136/bmj.b1793 |
ContentType | Journal Article |
Copyright | The Author(s), 2024 The Author(s), 2024. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s), 2024 2024 SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses |
Copyright_xml | – notice: The Author(s), 2024 – notice: The Author(s), 2024. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s), 2024 2024 SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses |
DBID | AFRWT AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. KB0 M0S NAPCQ PHGZM PHGZT PIMPY PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1177/17539447241290438 |
DatabaseName | Sage Journals GOLD Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database ProQuest Central Health & Medical Collection (via ProQuest) ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Nursing & Allied Health Premium Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals (DOAJ) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals (DOAJ) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: AFRWT name: Sage Journals GOLD Open Access url: http://journals.sagepub.com/ sourceTypes: Publisher – sequence: 5 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1753-9455 |
ExternalDocumentID | oai_doaj_org_article_90f5ba488d6947ed9eff50d10a047172 PMC11618966 39470690 10_1177_17539447241290438 10.1177_17539447241290438 |
Genre | Systematic Review Journal Article |
GroupedDBID | --- -TM 01A 0R~ 123 29Q 4.4 53G 54M 5RE 5VS 7RV 7X7 8FI 8FJ AABMB AADUE AAQDB AARDL AARIX AASGM ABAFQ ABAWP ABEIX ABFWQ ABJIS ABKRH ABQXT ABRHV ABUWG ABVFX ABXGC ACARO ACDSZ ACDXX ACGFS ACOFE ACROE ACRPL ADBBV ADEBD ADNMO ADOGD ADYCS ADZZY AEQLS AERKM AEUHG AEWDL AEXNY AFCOW AFEET AFKRA AFKRG AFRWT AFUIA AFWMB AGNHF AGQPQ AHHFK AJUZI ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS ARTOV ASPBG AUTPY AVWKF AYAKG AZFZN B8M BCNDV BDDNI BENPR BKEYQ BKSCU BPHCQ BSEHC BVXVI CAG CCPQU CDWPY CFDXU COF CS3 DC- DC. DOPDO EBS EJD EMOBN F5P FEDTE FYUFA GROUPED_DOAJ GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION H13 HF~ HMCUK HVGLF HYE HZ~ J8X K.F N9A NAPCQ O9- OK1 P.B PHGZM PHGZT PIMPY PQQKQ ROL RPM S01 SAUOL SCDPB SCNPE SFC UKHRP ZONMY ZPPRI ZRKOI ZSSAH AAYXX ACHEB CITATION CGR CUY CVF ECM EIF NPM PPXIY 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c485t-cea95bdf809b5f8c974d1afcaa0d2d084ca0f22c1fa5a79e512509e5a4d18d4e3 |
IEDL.DBID | 7X7 |
ISSN | 1753-9447 1753-9455 |
IngestDate | Wed Aug 27 01:21:46 EDT 2025 Thu Aug 21 18:34:58 EDT 2025 Thu Sep 04 22:30:17 EDT 2025 Fri Jul 25 21:05:20 EDT 2025 Mon Jul 21 05:55:29 EDT 2025 Tue Jul 01 05:28:17 EDT 2025 Tue Jun 17 22:26:29 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | STEMI percutaneous coronary intervention prediction model systematic review no-reflow phenomenon |
Language | English |
License | This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c485t-cea95bdf809b5f8c974d1afcaa0d2d084ca0f22c1fa5a79e512509e5a4d18d4e3 |
Notes | ObjectType-Article-1 ObjectType-Evidence Based Healthcare-3 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
ORCID | 0009-0006-2660-6176 |
OpenAccessLink | https://www.proquest.com/docview/3150529112?pq-origsite=%requestingapplication% |
PMID | 39470690 |
PQID | 3150529112 |
PQPubID | 4450850 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_90f5ba488d6947ed9eff50d10a047172 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11618966 proquest_miscellaneous_3121590554 proquest_journals_3150529112 pubmed_primary_39470690 crossref_primary_10_1177_17539447241290438 sage_journals_10_1177_17539447241290438 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-01-01 |
PublicationDateYYYYMMDD | 2024-01-01 |
PublicationDate_xml | – month: 01 year: 2024 text: 2024-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | London, England |
PublicationPlace_xml | – name: London, England – name: England – name: Thousand Oaks – name: Sage UK: London, England |
PublicationTitle | Therapeutic advances in cardiovascular disease |
PublicationTitleAlternate | Ther Adv Cardiovasc Dis |
PublicationYear | 2024 |
Publisher | SAGE Publications SAGE PUBLICATIONS, INC SAGE Publishing |
Publisher_xml | – name: SAGE Publications – name: SAGE PUBLICATIONS, INC – name: SAGE Publishing |
References | Wolff, Moons, Riley 2019; 170 Moons, de Groot, Bouwmeester 2014; 11 Stajic, Milicevic, Kafedzic 2022; 26 Kumar, Ammar, Saghir 2022; 171 Moons, Altman, Reitsma 2015; 162 Scarpone, Cenko, Manfrini 2018; 24 Tanaka, Imanishi, Kitabata 2009; 30 Reed, Rossi, Cannon 2017; 389 Steyerberg, Harrell 2016; 69 Dai, Liu, Zhou 2022; 52 Wong, Leung, Richardson 2012; 28 Xiao, Fu, Wang 2019; 25 Kennedy, Kim, Martin 2023; 366 Douglas, Yvonne, Patrick 2009; 338 Gür, Türkoǧlu, Taşkin 2014; 234 Uyarel, Ayhan, Cicek 2012; 23 Bouleti, Mewton, Germain 2015; 108 Boden, Eagle, Granger 2007; 50 Hamirani, Wong, Kramer 2014; 7 van Smeden, Moons, de Groot 2019; 28 Gupta, Gupta 2016; 68 Kumar, O’Connor, Kumar 2019; 17 Van Calster, McLernon, van Smeden 2019; 17 Niccoli, Burzotta, Galiuto 2009; 54 Ndrepepa, Tiroch, Fusaro 2010; 55 Zhang, Ji, Du 2021; 83 Debray, Koffijberg, Nieboer 2014; 33 Nijveldt, Beek, Hirsch 2008; 52 Amabile, Jacquier, Gaudart 2010; 103 Xu, Song, Xu 2021; 46 Fajar, Heriansyah, Rohman 2018; 70 Liu, Ye, Chen 2022; 9 Steyerberg, Vickers, Cook 2010; 21 Yang, Cong, Lu 2020; 99 Rezkalla, Stankowski, Hanna 2017; 10 Rossington, Sol, Masoura 2020; 7 Wang, Chen, Wang 2013; 124 Liu, Wang, Wang 2022; 18 Dogan, Ozpelit, Akdeniz 2015; 31 Hahn, Jeon, Geum 2023; 21 Ibanez, James, Agewall 2017; 39 Salama, Khalil, Al-Zaky 2020; 13 Park, Han 2018; 286 Moons, Wolff, Riley 2019; 170 Konijnenberg, Damman, Duncker 2020; 116 Yang, Cong, Lu 2021; 9 Courvoisier, Combescure, Agoritsas 2011; 64 Richard, Joie, Kym 2020; 368 Ozkalayci, Turkyilmaz, Karagoz 2022; 73 Bayramoğlu, Taşolar, Kaya 2018; 31 Wang, Zhou, Chen 2015; 38 Niccoli, Kharbanda, Crea 2010; 31 Russo, Montone, D’amario 2021; 10 Soeda, Higuma, Abe 2017; 18 bibr11-17539447241290438 bibr24-17539447241290438 bibr37-17539447241290438 Dogan NB (bibr29-17539447241290438) 2015; 31 bibr17-17539447241290438 bibr1-17539447241290438 bibr44-17539447241290438 bibr31-17539447241290438 bibr7-17539447241290438 bibr49-17539447241290438 bibr36-17539447241290438 bibr16-17539447241290438 bibr6-17539447241290438 bibr10-17539447241290438 Douglas GA (bibr51-17539447241290438) 2009; 338 Stajic Z (bibr20-17539447241290438) 2022; 26 bibr18-17539447241290438 bibr2-17539447241290438 bibr53-17539447241290438 bibr43-17539447241290438 bibr32-17539447241290438 bibr42-17539447241290438 bibr22-17539447241290438 bibr12-17539447241290438 bibr28-17539447241290438 bibr52-17539447241290438 bibr8-17539447241290438 bibr38-17539447241290438 bibr47-17539447241290438 bibr34-17539447241290438 bibr9-17539447241290438 bibr41-17539447241290438 bibr54-17539447241290438 bibr14-17539447241290438 bibr21-17539447241290438 bibr4-17539447241290438 bibr39-17539447241290438 bibr13-17539447241290438 bibr3-17539447241290438 bibr19-17539447241290438 bibr26-17539447241290438 bibr33-17539447241290438 Richard DR (bibr48-17539447241290438) 2020; 368 bibr40-17539447241290438 bibr5-17539447241290438 bibr30-17539447241290438 bibr50-17539447241290438 Yang L (bibr27-17539447241290438) 2020; 99 bibr46-17539447241290438 bibr55-17539447241290438 bibr25-17539447241290438 Wang J-W (bibr23-17539447241290438) 2013; 124 bibr15-17539447241290438 bibr35-17539447241290438 bibr45-17539447241290438 |
References_xml | – volume: 30 start-page: 1348 year: 2009 end-page: 1355 article-title: Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study publication-title: Eur Heart J – volume: 7 year: 2020 article-title: No-reflow phenomenon and comparison to the normal-flow population postprimary percutaneous coronary intervention for ST elevation myocardial infarction: case-control study (NORM PPCI) publication-title: Open Heart – volume: 368 year: 2020 article-title: Calculating the sample size required for developing a clinical prediction model publication-title: BMJ – volume: 38 start-page: 208 year: 2015 end-page: 215 article-title: A risk score for no reflow in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention publication-title: Clin Cardiol – volume: 46 start-page: 100676 year: 2021 article-title: A scoring system to predict no-reflow phenomenon in elective percutaneous coronary intervention: the RECOVER Score publication-title: Current Problems Cardiol – volume: 54 start-page: 281 year: 2009 end-page: 292 article-title: Myocardial no-reflow in humans publication-title: J Am Coll Cardiol – volume: 11 year: 2014 article-title: Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist publication-title: PLoS Med – volume: 25 start-page: 5864 year: 2019 end-page: 5877 article-title: Development and validation of risk nomogram model predicting coronary microvascular obstruction in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous catheterization publication-title: Medical Sci Monitor – volume: 234 start-page: 415 year: 2014 end-page: 420 article-title: Paraoxonase–1 activity and oxidative stress in patients with anterior ST elevation myocardial infarction undergoing primary percutaneous coronary intervention with and without no-reflow publication-title: Atherosclerosis – volume: 26 start-page: 759 year: 2022 end-page: 770 article-title: Predicting no-reflow phenomenon prior to primary percutaneous coronary intervention using a novel probability risk score derived from clinical and angiographic parameters publication-title: Eur Rev Med Pharmacol Sci – volume: 69 start-page: 245 year: 2016 end-page: 247 article-title: Prediction models need appropriate internal, internal-external, and external validation publication-title: J Clin Epidemiol – volume: 21 start-page: 76 year: 2023 article-title: Intracoronary versus intravenous glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in patients with STEMI: a systematic review and meta-analysis publication-title: Thromb J – volume: 17 start-page: 230 year: 2019 article-title: Calibration: the Achilles heel of predictive analytics publication-title: BMC Medicine – volume: 99 year: 2020 article-title: Prediction of no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction publication-title: Medicine (United States) – volume: 116 start-page: 787 year: 2020 end-page: 805 article-title: Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction publication-title: Cardiovasc Res – volume: 103 start-page: 512 year: 2010 end-page: 521 article-title: Value of a new multiparametric score for prediction of microvascular obstruction lesions in ST-segment elevation myocardial infarction revascularized by percutaneous coronary intervention publication-title: Arch Cardiovascular Dis – volume: 55 start-page: 2383 year: 2010 end-page: 2389 article-title: 5-Year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction publication-title: J Am Coll Cardiol – volume: 389 start-page: 197 year: 2017 end-page: 210 article-title: Acute myocardial infarction publication-title: Lancet – volume: 64 start-page: 993 year: 2011 end-page: 1000 article-title: Performance of logistic regression modeling: beyond the number of events per variable, the role of data structure publication-title: J Clin Epidemiol – volume: 31 start-page: 2449 year: 2010 end-page: 2455 article-title: No-reflow: again prevention is better than treatment publication-title: Eur Heart J – volume: 23 start-page: 98 year: 2012 end-page: 104 article-title: Suboptimal coronary blood flow after primary percutaneous coronary intervention for acute myocardial infarction: incidence, a simple risk score, and prognosis publication-title: Coronary Artery Dis – volume: 366 start-page: 227 year: 2023 end-page: 235 article-title: Total ischemic time and age as predictors of PCI failure in STEMIs: a systematic review publication-title: Am J Medical Sci – volume: 39 start-page: 119 year: 2017 end-page: 177 article-title: 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) publication-title: European Heart J – volume: 70 year: 2018 article-title: The predictors of no reflow phenomenon after percutaneous coronary intervention in patients with ST elevation myocardial infarction: a meta-analysis publication-title: Indian Heart J – volume: 18 start-page: 155 year: 2022 end-page: 169 article-title: Development and validation of a clinical and laboratory-based nomogram for predicting coronary microvascular obstruction in NSTEMI patients after primary PCI publication-title: Ther Clin Risk Manage – volume: 10 start-page: 633 year: 2021 end-page: 642 article-title: Role of perilipin 2 in microvascular obstruction in patients with ST-elevation myocardial infarction publication-title: Eur Heart J: Acute Cardiovasc Care – volume: 108 start-page: 661 year: 2015 end-page: 674 article-title: The no-reflow phenomenon: state of the art publication-title: Arch Cardiovasc Dis – volume: 21 start-page: 128 year: 2010 end-page: 138 article-title: Assessing the performance of prediction models: a framework for traditional and novel measures publication-title: Epidemiology – volume: 52 year: 2022 article-title: A score system to predict no-reflow in primary percutaneous coronary intervention: the PIANO Score publication-title: Eur J Clin Invest – volume: 170 year: 2019 article-title: PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration publication-title: Ann Intern Med – volume: 52 start-page: 181 year: 2008 end-page: 189 article-title: Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury publication-title: J Am Coll Cardiol – volume: 24 start-page: 2927 year: 2018 end-page: 2933 article-title: Coronary no-reflow phenomenon in clinical practice publication-title: Curr Pharm Des – volume: 31 start-page: 144 year: 2018 end-page: 149 article-title: Prediction of no-reflow and major adverse cardiovascular events with a new scoring system in STEMI patients publication-title: J Interventional Cardiol – volume: 9 start-page: 126 year: 2021 article-title: A nomogram for predicting the risk of no-reflow after primary percutaneous coronary intervention in elderly patients with ST-segment elevation myocardial infarction publication-title: Annal Transl Med – volume: 170 start-page: 51 year: 2019 end-page: 58 article-title: PROBAST: a tool to assess the risk of bias and applicability of prediction model studies publication-title: Ann Intern Med – volume: 68 start-page: 539 year: 2016 end-page: 551 article-title: No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction publication-title: Indian Heart J – volume: 286 start-page: 800 year: 2018 end-page: 809 article-title: Methodologic guide for evaluating clinical performance and effect of artificial intelligence technology for medical diagnosis and prediction publication-title: Radiology – volume: 33 start-page: 2341 year: 2014 end-page: 2362 article-title: Meta-analysis and aggregation of multiple published prediction models publication-title: Stat Med – volume: 10 start-page: 215 year: 2017 end-page: 223 article-title: Management of no-reflow phenomenon in the catheterization laboratory publication-title: JACC: Cardiovas Interventions – volume: 17 start-page: 605 year: 2019 end-page: 623 article-title: Coronary no-reflow in the modern era: a review of advances in diagnostic techniques and contemporary management publication-title: Expert Rev Cardiovasc Ther – volume: 124 start-page: 153 year: 2013 end-page: 160 article-title: Development and validation of a clinical risk score predicting the no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction publication-title: Cardiology (Switzerland) – volume: 162 year: 2015 article-title: Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration publication-title: Ann Intern Med – volume: 9 start-page: 966299 year: 2022 article-title: A nomogram risk prediction model for no-reflow after primary percutaneous coronary intervention based on rapidly accessible patient data among patients with ST-segment elevation myocardial infarction and its relationship with prognosis publication-title: Front Cardiovasc Med – volume: 28 start-page: 2455 year: 2019 end-page: 2474 article-title: Sample size for binary logistic prediction models: beyond events per variable criteria publication-title: Stat Methods Med Res – volume: 7 start-page: 940 year: 2014 end-page: 952 article-title: Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV remodeling and outcomes after myocardial infarction: a systematic review and meta-analysis publication-title: JACC Cardiovasc Imaging – volume: 31 start-page: 576 year: 2015 end-page: 581 article-title: Simple clinical risk score for no-reflow prediction in patients undergoing primary percutaneous coronary intervention with acute STEMI publication-title: Pakistan J Med Sci – volume: 50 start-page: 917 year: 2007 end-page: 929 article-title: Reperfusion strategies in acute ST-segment elevation myocardial infarction: a comprehensive review of contemporary management options publication-title: J Am College Cardiol – volume: 171 start-page: 32 year: 2022 end-page: 39 article-title: Development and validation of a novel risk stratification model for slow-flow/no-reflow during primary percutaneous coronary intervention (the RK-SF/NR Score) publication-title: Am J Cardiol – volume: 83 start-page: 217 year: 2021 end-page: 223 article-title: Establishment and evaluation of nomogram model for predicting the risk of no reflow after percutaneous coronary intervention in patients with acute myocardial infarction publication-title: Indian J Pharm Sci – volume: 13 start-page: 988 year: 2020 end-page: 995 article-title: MicroRNA–208a: a good diagnostic marker and a predictor of no-reflow in STEMI patients undergoing primary percutaneuos coronary intervention publication-title: J Cardiovasc Transl Res – volume: 73 start-page: 365 year: 2022 end-page: 373 article-title: A clinical score to predict “corrected thrombolysis in myocardial infarction frame count” in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention publication-title: Angiology – volume: 338 year: 2009 article-title: Prognosis and prognostic research: validating a prognostic model publication-title: BMJ – volume: 28 start-page: 1971 year: 2012 end-page: 1981 article-title: Cardiac magnetic resonance derived late microvascular obstruction assessment post ST-segment elevation myocardial infarction is the best predictor of left ventricular function: a comparison of angiographic and cardiac magnetic resonance derived measurements publication-title: Int J Cardiovasc Imaging – volume: 18 start-page: 103 year: 2017 end-page: 110 article-title: Morphological predictors for no reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction caused by plaque rupture publication-title: Eur Heart J Cardiovascular Imaging – ident: bibr15-17539447241290438 doi: 10.7326/M14-0698 – ident: bibr1-17539447241290438 doi: 10.1016/S0140-6736(16)30677-8 – ident: bibr12-17539447241290438 doi: 10.1016/j.jcin.2016.11.059 – volume: 31 start-page: 576 year: 2015 ident: bibr29-17539447241290438 publication-title: Pakistan J Med Sci – ident: bibr49-17539447241290438 doi: 10.1177/0962280218784726 – ident: bibr13-17539447241290438 doi: 10.1371/journal.pmed.1001744 – ident: bibr52-17539447241290438 doi: 10.1148/radiol.2017171920 – ident: bibr41-17539447241290438 doi: 10.1016/j.cpcardiol.2020.100676 – ident: bibr31-17539447241290438 doi: 10.1136/openhrt-2019-001215 – ident: bibr45-17539447241290438 doi: 10.1016/j.jcmg.2014.06.012 – ident: bibr43-17539447241290438 doi: 10.1093/cvr/cvz301 – ident: bibr10-17539447241290438 doi: 10.1080/14779072.2019.1653187 – ident: bibr3-17539447241290438 doi: 10.1186/s12959-023-00519-x – ident: bibr11-17539447241290438 doi: 10.1093/eurheartj/ehq299 – ident: bibr53-17539447241290438 doi: 10.1016/j.jclinepi.2015.04.005 – ident: bibr8-17539447241290438 doi: 10.1016/j.jacc.2009.12.054 – ident: bibr28-17539447241290438 doi: 10.1111/joic.12463 – ident: bibr33-17539447241290438 doi: 10.1016/j.ihj.2018.01.032 – ident: bibr46-17539447241290438 doi: 10.1097/EDE.0b013e3181c30fb2 – volume: 124 start-page: 153 year: 2013 ident: bibr23-17539447241290438 publication-title: Cardiology (Switzerland) – ident: bibr30-17539447241290438 doi: 10.1016/j.acvd.2010.09.005 – ident: bibr4-17539447241290438 doi: 10.1016/j.jacc.2007.04.084 – ident: bibr32-17539447241290438 doi: 10.1016/j.amjms.2023.06.011 – ident: bibr9-17539447241290438 doi: 10.1016/j.jacc.2009.03.054 – ident: bibr6-17539447241290438 doi: 10.1016/j.acvd.2015.09.006 – ident: bibr21-17539447241290438 doi: 10.3389/fcvm.2022.966299 – ident: bibr25-17539447241290438 doi: 10.12659/MSM.915960 – ident: bibr37-17539447241290438 doi: 10.1007/s12265-020-10020-9 – ident: bibr42-17539447241290438 doi: 10.1007/s10554-012-0021-9 – ident: bibr44-17539447241290438 doi: 10.1016/j.jacc.2008.04.006 – ident: bibr36-17539447241290438 doi: 10.1093/eurheartj/ehp122 – ident: bibr7-17539447241290438 doi: 10.2174/1381612824666180702112536 – volume: 26 start-page: 759 year: 2022 ident: bibr20-17539447241290438 publication-title: Eur Rev Med Pharmacol Sci – ident: bibr22-17539447241290438 doi: 10.1002/clc.22376 – ident: bibr38-17539447241290438 doi: 10.1093/ehjacc/zuaa004 – ident: bibr19-17539447241290438 doi: 10.1016/j.amjcard.2022.01.044 – ident: bibr26-17539447241290438 doi: 10.36468/pharmaceutical-sciences.spl.353 – volume: 368 year: 2020 ident: bibr48-17539447241290438 publication-title: BMJ – ident: bibr17-17539447241290438 doi: 10.1111/eci.13686 – ident: bibr2-17539447241290438 doi: 10.1093/eurheartj/ehx393 – ident: bibr54-17539447241290438 doi: 10.1002/sim.6080 – ident: bibr47-17539447241290438 doi: 10.1186/s12916-019-1466-7 – ident: bibr39-17539447241290438 doi: 10.1016/j.atherosclerosis.2014.03.005 – ident: bibr35-17539447241290438 doi: 10.1093/ehjci/jev341 – ident: bibr55-17539447241290438 doi: 10.1007/978-0-387-77244-8 – ident: bibr18-17539447241290438 doi: 10.1177/00033197211045021 – ident: bibr40-17539447241290438 doi: 10.2147/TCRM.S353199 – ident: bibr34-17539447241290438 doi: 10.7326/M18-1377 – ident: bibr5-17539447241290438 doi: 10.1016/j.ihj.2016.04.006 – ident: bibr50-17539447241290438 doi: 10.1016/j.jclinepi.2010.11.012 – ident: bibr14-17539447241290438 doi: 10.7326/M18-1376 – ident: bibr16-17539447241290438 doi: 10.1097/MCA.0b013e32834f1b8a – volume: 99 year: 2020 ident: bibr27-17539447241290438 publication-title: Medicine (United States) – ident: bibr24-17539447241290438 doi: 10.21037/atm-20-8003 – volume: 338 year: 2009 ident: bibr51-17539447241290438 publication-title: BMJ doi: 10.1136/bmj.b1793 |
SSID | ssj0059077 |
Score | 2.3037236 |
SecondaryResourceType | review_article |
Snippet | Background:
The no-reflow (NRF) phenomenon is the “Achilles heel” of interventionists after performing percutaneous coronary intervention (PCI) in patients... The no-reflow (NRF) phenomenon is the "Achilles heel" of interventionists after performing percutaneous coronary intervention (PCI) in patients with ST-segment... Background: The no-reflow (NRF) phenomenon is the “Achilles heel” of interventionists after performing percutaneous coronary intervention (PCI) in patients... |
SourceID | doaj pubmedcentral proquest pubmed crossref sage |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 17539447241290438 |
SubjectTerms | Age Factors Angioplasty Cardiovascular disease Clinical Decision Rules Clinical Decision-Making - methods Content analysis Coronary Circulation Decision Support Techniques Heart attacks Humans Ischemia No-Reflow Phenomenon - diagnosis No-Reflow Phenomenon - etiology No-Reflow Phenomenon - physiopathology Percutaneous Coronary Intervention - adverse effects Predictive Value of Tests Reproducibility of Results Risk Assessment Risk Factors ST Elevation Myocardial Infarction - diagnosis ST Elevation Myocardial Infarction - physiopathology ST Elevation Myocardial Infarction - therapy Systematic Review Thrombolytic drugs Time Factors Treatment Outcome |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1baxQxFD5IH8QX8e5olQiCIAQzM8nMxDcVSxEqgi30bcjkogvtTNkL0t_WP-c5SXa7SxVffFuSkD2TfJl8Z3LyHYDXTRfQ0RhaLmsvOfobNR_KRvDWORlso2sTv0MefW0OT-SXU3W6leqLYsKSPHAauHdaBDUYhJlrtGy90z4EJVwpsBN0ReLbV2ixdqbSO1ihy9fmM0ySVyI5Si1li9tVpensa2cXimL9f2KYNwMlt6K94gZ0cA_uZubIPiSL78MtPz6A20f5bPwhXH2b028KY2bI6tg4cfzfs-kXozAuElqYRjYb2fdjTnfK44yw80vcywgjZ1gVEPSxNIutLhjdMJv_mKjLiyRLwS783K6QUfpptWCW9A-odLYVOvmeGXYtEM3S5Rg2Bba-hYl9JUvJAMrEs3gEJwefjz8d8pyagVvZqSW33mg1uNAJPajQWfRKXGmCNUa4yolOWiNCVdkyGGVa7ZFWIDPxymCzzklfP4Y9fGr_FJiwspTIYyqD3MwrZapOWUOy8wG5kQ8FvF1PVZ8ftS-zSPmNeS3gI03mpiGJZ8cChFSfIdX_C1IF7K-h0OcVvejrklL-4daA1a821bgW6YAlDTq2QQKlBTK0Ap4k5GwsQTtbUoUuoNvB1I6puzXj7GfU-y4pqQG6pQW8Ifhd2_TXYXj2P4bhOdypkMGl7037sLecr_wLZGDL4WVcbL8BITswQw priority: 102 providerName: Directory of Open Access Journals – databaseName: Sage Journals GOLD Open Access dbid: AFRWT link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3batwwEBVpAqUvJb27SYsKhUJBjWxLtpWXkpYuoZBS2g3Nm5F1SReydvCuCfm2_FxmbHmTJSn0zUjCGksz1pFmdIaQ91nhYaNR5UykTjDYb6SsijPOcmuFN5lKdX8OefQjOzwW30_kyQZpxrswYQQXnzCsCiTqf9Zo3XgavRecjHtIL6mEyGH5SRT6sj53y3k5HHePWTWwBP3T3Rxd2wYDIi_ZeL3tAdlC6nIwia2Dya8_0_HnLWGv2OdjgQ4Y9hAcofd2uraU9Yz_98HUu9GWt0LG-lVssk0eB_hJDwZ9eUI2XP2UPDwKDvZn5Opni88YC00BGtK6YdDvWXNBMRYM2Rqams5q-nvK8GJ6P610fgkLIiraGVR5sJy-NDC2LiheU2tPG3zl-cBtQc9dazqApa7pFtQgiQKWzm7FX-5TTW9Ypulww4Y2no5XOeFdg6QoAKbzWTwnx5Nv06-HLOR3YEYUcsmM00pW1hdcVdIXBrY2NtbeaM1tYnkhjOY-SUzstdS5coBNAN44qaFZYYVLX5BN-Gr3ilBuRCwADCUaAJ6TUieFNBq56z0ALOcj8nGcqjJ8ahkHpvM78xqRLziZq4bIwN0XNO1pGQy6VNzLSsPvz2ZK5M4q573kNuag3LBFTiKyO6pCOSp1mcaYNxDWF6h-t6oGg0YvzTDo0AZQmOIA8yLyctCclSQgZ47U0hEp1nRqTdT1mnr2tycNjzEzAuxtI_IB1e9Gpn8Ow-v_brlDHiWA9YaTqV2yuWw79waw2rJ6G-zrGlKjPYM priority: 102 providerName: SAGE Publications |
Title | Predicting the no-reflow phenomenon in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a systematic review of clinical prediction models |
URI | https://journals.sagepub.com/doi/full/10.1177/17539447241290438 https://www.ncbi.nlm.nih.gov/pubmed/39470690 https://www.proquest.com/docview/3150529112 https://www.proquest.com/docview/3121590554 https://pubmed.ncbi.nlm.nih.gov/PMC11618966 https://doaj.org/article/90f5ba488d6947ed9eff50d10a047172 |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ta9swEBZbC2Nfxt7nrgsaDAYDMb9ItrUvox0NZdBSupTlm5H10gY6O7MTyn7b_tzuZCVp6LZPMZJwTtad9Jx0eo6Qd3npwNGoC8Yzyxn4GxmrkzxmhTHc6Vxmyu9Dnpzmxxf861RMw4ZbH8IqV3Oin6hNq3GP_GOWYMo1MM308_wnw6xReLoaUmjcJ7sJIBFM3VBM1w6XAMfPJ1cBSM4k50U41UTCJSzDIljAUomnYVvrkqfv_xvmvBs6eSv-yy9J48fkUcCS9GAY_Cfknm2ekgcn4bT8Gfl91uEzBjZTwHm0aRn873V7QzGwC6kX2obOGvptwvCWuR8j-uMXrG6oNddQ5cAMfGmgX-0p3jnrLlt85XwgqqBz2-klYEzbLnuqkREBS2e3gik_UUU3lNF0uC5DW0dX9zLhXYOkKADm5umfk4vx0eTLMQvJGpjmpVgwbZUUtXFlLGvhSg1-ikmU00rFJjVxybWKXZrqxCmhCmkBaABWsUJBs9Jwm70gO9Br-4rQWPOEA7JJFaA1K4RKS6EVEtE7QEvWReTDaqiq0NUqCbTld8Y1Ioc4mOuGSKftC9rusgrWWcnYiVrBXGZyyQtrpHVOxCaJQVPB300jsr9ShSrYeF9tNDIib9fVYJ145DJ8dGgDkErGgNki8nLQnLUkIGeBPNERKbd0akvU7ZpmduUZwBNMcwCOakTeo_ptZPrnZ9j7fw9ek4cpoLVhb2mf7Cy6pX0DaGtRj7xJjcjuwfj8-wR-D49Oz85Hfu_iD-uELfE |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3rb9MwED-NToJ9QbwJDDASCAnJIkntJkGaEINNHVurCTpp34Ljx1ZpNKUPTfvbkPjbuEucdtWAb_tWOZZ7ts_3sO9-B_Cqkzp0NIqEi7YVHP2NNi-iTsgTY4TTnaytqnvIXr_TPRJfjuXxGvxucmEorLKRiZWgNqWmO_J37YhKruHRjD-Mf3KqGkWvq00JDeVLK5itCmLMJ3bs24tzdOGmW3ufcb9fx_HuzuBTl_sqA1yLVM64tiqThXFpmBXSpRoNbBMpp5UKTWzCVGgVujjWkVNSJZlFDYlK1kqF3VIjbBvHvQHrgi5QWrC-vdM__NroAomuZ1XeBZ0CngmR-HdVgnyiNmpCFRpn9B63ohmrAgJ_s3qvBm9eikCrlOLuHbjtrVn2sWa_u7BmR_fgZs-_19-HX4cT-k2h1QwtTTYqOf7vWXnOKLSMwB_KERuO2LcBpzz3ikvYjwvUr8S3Z_jJ4QpXrR4Adsoo621yUtKQ4xoqg43tRM_RyrXlfMo0YTJQ6_BSOOd7ptgStJrVCTusdKzJDMWxakqJAKoONH0AR9eykQ-hhbO2j4GFWkQCbatYob1opVRxKrUiKHyH9pp1Abxttir3U80jD5x-ZV8D2KbNXHQkQO-qoZyc5F4-5FnoZKFQmppOJhJrMuucDE0U4llBjzsOYLNhhdxLmWm-PBMBvFx8RvlAjz71omMfNOqyEK3GAB7VnLOgBOlMCKk6gHSFp1ZIXf0yGp5WGOQRFVpAVzmAN8R-S5r-uQxP_j-DF3CrO-gd5Ad7_f2nsBGj7VjfdG1CazaZ22do-82K5_6AMfh-3Wf6DyHabzE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3bbtQwEB3BVqp4QdwJFDASEhKSqZPYm4S3clmVS6sKtqJvkeNLWakkq-yuEN_GzzGTONuuWiTeIttxJvbYPuMZHwO8GOceDY0q4zJ1kqO9kfIqHgueWSu9GRep7vYhDw7H-8fy04k6CRtudBYmtODiNYVVoUTdZE2je279bvAx7hK7ZCFlhqtPUpAr6zps4WdyMYKtvcnX79NhLlZo-nXXq-ALnN4Ifs0rK9lYmToC_6tQ5-XgyQsRYN2iNLkFNwOaZHt999-Ga66-A9sHwV9-F_4ctfRMoc0MkR6rG47fPWt-MQrtIvKFpmazmn2bcjpn3vUS-_kb1zfSmzPM8jgQutRAwLpgdOqsPW2oynlPVcHmrjUrRJmuWS2YIU4ESp1dCKd8wzQ7J41m_YEZ1ng2nMzEunpJSQC6nWdxD44nH6bv9nm4roEbmaslN04XqrI-F0WlfG7QUrGx9kZrYRMrcmm08EliYq-VzgqHUAPRilMai-VWuvQ-jPCv3UNgwshYIrZJNOI1p5ROcmU0UdF7xEvOR_Bq6Koy_GoZB-LyS_0awVvqzHVBItTuEpr2tAzjsyyEV5XG2cyOC5k5WzjvlbCxQF1FizeJYGdQhXLQ0TKN6RpAXC4w-_k6G8cnOV36RscyCKoKgagtgge95qwlQTkzYoqOIN_QqQ1RN3Pq2Y-OAzymiw7QVI3gJanfuUz_bIZH_13yGWwfvZ-UXz4efn4MNxJEcf2e0w6Mlu3KPUEUtqyehqH2FzojLAA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Predicting+the+no-reflow+phenomenon+in+ST-elevation+myocardial+infarction+patients+undergoing+primary+percutaneous+coronary+intervention%3A+a+systematic+review+of+clinical+prediction+models&rft.jtitle=Therapeutic+advances+in+cardiovascular+disease&rft.au=Ebrahimi%2C+Reza&rft.au=Rahmani%2C+Mahdi&rft.au=Fallahtafti%2C+Parisa&rft.au=Ghaseminejad-Raeini%2C+Amirhossein&rft.date=2024-01-01&rft.issn=1753-9455&rft.eissn=1753-9455&rft.volume=18&rft.spage=17539447241290438&rft_id=info:doi/10.1177%2F17539447241290438&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1753-9447&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1753-9447&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1753-9447&client=summon |